US 10016480
Peptide-based methods for treating pancreatic cancer
granted A61KA61K31/282A61K31/337
Quick answer
US patent 10016480 (Peptide-based methods for treating pancreatic cancer) held by The United States of America as Represented by the Secretary, Dept. of Health and Human Services expires Mon Jul 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by the Secretary, Dept. of Health and Human Services
- Grant date
- Tue Jul 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K31/282, A61K31/337, A61K31/4745, A61K31/513